| Literature DB >> 21987590 |
Maria C Ramos1, Saleta Sierra, Carlos Ramirez, Javier Velasco, Javier S Burgos.
Abstract
This work describes a novel mechanism of neuroprotection by simvastatin: the modulation of seladin-1, an enzyme involved in Alzheimer's disease. Genomic and proteomic studies in human neuronal cells showed seladin-1 production to be increased in a dose- and time-dependent manner by simvastatin. This was confirmed in mice by immunohistochemical and qRT-PCR studies.Entities:
Mesh:
Substances:
Year: 2012 PMID: 21987590 DOI: 10.3233/JAD-2011-111118
Source DB: PubMed Journal: J Alzheimers Dis ISSN: 1387-2877 Impact factor: 4.472